Our company
About Better Cann Pharmaceutical
Better Cann Pharmaceutical is a research-driven biopharmaceutical company developing standardized, plant-derived therapeutics for complex neurological and chronic medical conditions.
Overview
Better Cann Pharmaceutical was founded in 2009 as a research-driven biopharmaceutical company focused on developing standardized cannabinoid-based therapeutics for complex medical conditions.
The company combines proprietary biological source genetics, formulation development, human clinical experience, and long-term treatment knowledge — with the goal of translating plant-derived science into reproducible, pharmaceutical-grade care.
Mission
To translate proprietary biological source genetics, clinical knowledge, and pharmaceutical precision into standardized therapies for patients with complex medical needs.
Vision
A future in which plant-derived medicine meets the same standards of consistency, evidence, and precision as any modern pharmaceutical therapy.
Scientific philosophy
- Medicine first. Every decision starts from the patient and the clinical question, not from the plant.
- Science-led. We prioritize measurable, reproducible evidence and transparent methodology over marketing claims.
- Built on proprietary biological source genetics. Controlled, stabilized source material is the foundation of consistent formulations.
History
Our milestones
A timeline of the company since its founding in 2009. Items pending verification are omitted from public display.
2009
Company founded
Better Cann Pharmaceutical is established to pursue clinical and pharmaceutical development of cannabinoid-based medicine.
2009+
Development of proprietary genetics
Long-term selection and stabilization of proprietary biological source genetics begins.
2010s
Early patient treatment experience
Accumulation of real-world treatment experience across complex medical conditions.
2010s
Multi-center clinical research
Participation in human clinical research, including children with treatment-resistant epilepsy at major Israeli medical centers.
—
Product development milestones
Development of medical formulations, oils, extracts, and therapeutic products from controlled source material.
—
International partnership expansion
Development of a strategy for clinical, licensing, and development partnerships across markets.
Today
Current research and development
Ongoing pharmaceutical development, quality work, and expansion of the biological source platform.
Leadership
Guided by science and medicine
Chief Executive Officer
Corporate strategy
Chief Scientific Officer
Scientific & clinical research
Medical Director
Medical affairs & pharmacovigilance
Quality Director
Quality & compliance
Company facts
At a glance
- Official name
- Better Cann Pharmaceutical Ltd.
- Founded
- 2009
- Headquarters
- Israel
- Industry
- Biopharmaceuticals · Cannabinoid-based therapeutics · Clinical research
- Parent entity
- Better Holdings